Bdr

• 

  BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India

  BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.

• 

  Bangladesh Court Upholds Death Sentence Of 139 Soldiers In 2009 BDR Revolt Case

  The Bangladesh High Court today upheld the death sentence of 139 and the life imprisonment of 146 convicted soldiers involved in a 2009 mutiny and their role in the massacre of 74 people, including 57 Army officers, in the country's biggest-ever criminal case.

• 

  A Long Road To Recovery For Encephalitis Survivors In Uttar Pradesh's Gorakhpur

  Gorakhpur, Uttar Pradesh: Raj Gautam, 2, is recovering from encephalitis in Uttar Pradesh’s Baba Raghav Das hospital in Gorakhpur, which saw deaths of 23 children on August 10 due to short supply of oxygen. The two-year-old’s road to recovery has been slow. His physician Dr PN Gupta said that he has lost sensation in his right leg. “We have ...

• 

  Two Indian Generics Makers End Battle to Copy Drugs Amid Patent Debate

  Two Indian drug makers said they had given up a battle to copy drugs developed by Bristol Myers Squibb and AstraZeneca, blaming a lack of government support for cheap generics and pressure from Big Pharma.

• Pharma giant Novartis waits nervously on Glivec drug patent verdict today

  Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country.

• BDR seeks compulsory licence for cancer drug; offers 95 per cent cheaper generic copy

  Drug firm BDR Pharmaceuticals has applied for a compulsory licence to market generic version of US-based Bristol-Myers Squibb's cancer drug Dasatinib, sold under 'Sprycel' brand, promising to offer the product at price cheaper by over 95 per cent for a month's treatment.

• BDR Pharma seeks license to sell version of a cancer drug

  BDR Pharmaceuticals International Pvt Ltd has applied to the patents office, seeking permission to sell a generic version of Bristol-Myers Squibb Co's cancer drug, Dasatinib, through a so-called compulsory license mechanism, a BDR executive said on Monday.

• 250 Bangladesh patients, nurses jailed over mutiny

  A Bangladesh court has jailed more than 250 people including paramilitary guards and male nurses for joining a 2009 mutiny, prosecutors said on Sunday. Scores of senior army officers were killed during the uprising that began when soldiers at the Bangladeshi Rifles (BDR) headquarters in the capital Dhaka went on a killing spree, dumping the bodies...

• Lyka BDR International becomes subsidiary of Lyka Labs

  Lyka Labs hsa announced that Lyka BDR International has become a subsidiary of the company.The company made this announcement during the trading hours today, 14 May 2009.

• Bangladesh sets up six 'special courts' for trial of BDR soldiers

  Bangladesh on Sunday set up six "special courts" to try the suspected rebellious soldiers for the bloody mutiny by the paramilitary Bangladesh Rifles (BDR) that led to the massacre of 67 army officers.

• Banladesh arrests nearly 600 mutiny suspects

  Nearly 600 border guards of the paramilitary Bangladesh Rifles, allegedly involved in the bloody mutiny in February, have been arrested.

• Jamaat leader quizzed over BDR mutiny

  A senior leader of the fundamentalist Jamaat-e-Islami was questioned by sleuths on Monday in connection with last month's bloody mutiny at the paramilitary Bangladesh Rifles (BDR) headquarters, the first politician to be quizzed in the case.